Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 2Smoldering Multiple Myeloma 1Renal Insufficiency 1Bone Diseases 1

Interventions

Dexamethasone 13Bortezomib 8Cyclophosphamide 5Lenalidomide 4pomalidomide 3isatuximab 3Calcium Dobesilate 3Thalidomide 2Kidney Transplantation 2melflufen 1dexamethasone acetate 1dexamethasone 21-phosphate 1daratumumab 1carfilzomib 1belantamab mafodotin 1auricularum 1Zoledronic Acid 1Whole-Body Irradiation 1Tablets 1Ranitidine 1Plasmapheresis 1L-melphalanyl-p-L-fluorophenylalanine ethyl ester 1Drug Therapy 1Doxorubicin 1Diphenhydramine 1Data Collection 1Cyclosporine 1Bendamustine Hydrochloride 1BHQ880 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Renal Insufficiency × BHQ880 × Plasma cell × Clear all
NCT01337752 2020-12-17

Study in Patients With Untreated Multiple Myeloma and Renal Insufficiency

Novartis

Phase 2 Completed
9 enrolled
Plasma cell

Multiple Myeloma, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡